The invention relates to using one or several synthetic or natural furan
alkyls for preparing a drug for preventing and/or treating diabetes and
insulin resistance, thereby preventing the risks of cardiovascular,
nervous, cutaneous, renal, ocular and infectious diseases. The use of one
or several synthetic or natural furan alkyls for cosmetically treating
diabetes related skin disorders is also disclosed.